Skip to content
HowShorted

AnaptysBio, Inc. short interest in 2021

In 2021, AnaptysBio, Inc.'s disclosed short interest ran from 12.92% of shares outstanding on 15 Jan 2021 to 7.81% on 31 Dec 2021, a change of -5.11 percentage points. The year's high was 15.74% on 15 Apr 2021 and its low 7.81% on 31 Dec 2021, averaging 11.68% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.55 days on 31 Aug 2021. Full history: AnaptysBio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for AnaptysBio, Inc. in 2021

2021 in figures

Start of year
12.92% (15 Jan 2021)
End of year
7.81% (31 Dec 2021)
Change
-5.11 pp
High
15.74% (15 Apr 2021)
Low
7.81% (31 Dec 2021)
Average
11.68%
Highest days to cover
22.55 (31 Aug 2021)
SEC filings marked
9

Every report in 2021

AnaptysBio, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202112.92%7.26results (8-K)
29 Jan 202113.07%11.44
12 Feb 202113.67%9.92
26 Feb 202113.92%11.3010-K filed, results (8-K)
15 Mar 202114.38%3.29
31 Mar 202115.31%10.86
15 Apr 202115.74%19.35
30 Apr 202114.39%17.63
14 May 202114.49%18.0710-Q filed, results (8-K)
28 May 202113.80%19.23
15 Jun 202113.87%19.93
30 Jun 202111.34%8.01
15 Jul 202111.43%17.97
30 Jul 202110.63%14.17
13 Aug 202110.48%22.1310-Q filed, results (8-K)
31 Aug 202110.59%22.55
15 Sep 202110.15%19.59
30 Sep 20219.34%14.09
15 Oct 20219.01%16.56
29 Oct 20218.84%12.91
15 Nov 20218.47%11.6910-Q filed, results (8-K)
30 Nov 20218.34%12.60
15 Dec 20218.34%16.29
31 Dec 20217.81%11.88

See also: AnaptysBio, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.